Oruka Therapeutics (ORKA) Other Accumulated Expenses (2010 - 2024)
Oruka Therapeutics (ORKA) reported Other Accumulated Expenses of $591,000 for Q2 2024, down 49.5% from $1.17 million a year earlier and down 38.9% from the prior quarter.
Powered by 
Analysis
Oruka Therapeutics (ORKA) Other Accumulated Expenses (2010 - 2024) Analysis & Trends
At the end of FY2023, Oruka Therapeutics posted Other Accumulated Expenses of $175,000, down 72.0% from FY2022.
- Other Accumulated Expenses has a five-year compound annual growth rate of -15.8% (FY2018 to FY2023).
- By year, Other Accumulated Expenses came in at $625,000 in FY2022 (-57.1%), $1.46 million in FY2021 (+59.8%), $911,000 in FY2020 (+140.4%) and $379,000 in FY2019 (-8.2%).
- Five-year quarterly Other Accumulated Expenses spans a low of $175,000 in Q4 2023 and a high of $1.91 million in Q3 2021.
- Year over year, Other Accumulated Expenses gained in 1 of the last eight quarters, with an average decline of 36.7%.
- The high point for year-over-year Other Accumulated Expenses in five years was Q3 2021 (growth of 249.5%); the low point was Q4 2023 (a decline of 72.0%).
- Per Business Quant data, the three quarters before Q2 2024 came in at $968,000 (Q1 2024), $175,000 (Q4 2023) and $582,000 (Q3 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Oruka Therapeutics | 5.31 Bn | 3.37 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | 591,000.00 |
| Mar 31, 2024 | 968,000.00 |
| Dec 31, 2023 | 175,000.00 |
| Sep 30, 2023 | 582,000.00 |
| Jun 30, 2023 | 1.17 Mn |
| Mar 31, 2023 | 665,000.00 |
| Dec 31, 2022 | 625,000.00 |
| Sep 30, 2022 | 1.01 Mn |
| Jun 30, 2022 | 1.38 Mn |
| Mar 31, 2022 | 1.54 Mn |
| Dec 31, 2021 | 1.46 Mn |
| Sep 30, 2021 | 1.91 Mn |
| Jun 30, 2021 | 1.30 Mn |
| Mar 31, 2021 | 1.05 Mn |
| Dec 31, 2020 | 911,000.00 |
| Sep 30, 2020 | 545,000.00 |
| Jun 30, 2020 | 600,000.00 |
| Mar 31, 2020 | 799,000.00 |
| Dec 31, 2019 | 379,000.00 |
| Sep 30, 2019 | 857,000.00 |
API Access
Oruka Therapeutics Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=ORKA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "ORKA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=ORKA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();